## ValueSet Comparison between http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1010.6 vs http://hl7.org/fhir/ValueSet/vaccine-code

### Messages

Error | ValueSet.url | Values for url differ: 'http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1010.6' vs 'http://hl7.org/fhir/ValueSet/vaccine-code'
Error | ValueSet.version | Values for version differ: '20250411' vs '4.0.1'
Information | ValueSet.name | Values for name differ: 'CVXVaccinesAdministeredVaccineSet' vs 'VaccineAdministeredValueSet'
Information | ValueSet.title | Values for title differ: 'CVX Vaccines Administered Vaccine Set' vs 'Vaccine Administered Value Set'
Information | ValueSet.date | Values for date differ: '2025-04-11T01:08:38-04:00' vs '2019-11-01T09:29:23+11:00'
Information | ValueSet.publisher | Values for publisher differ: 'HL7 US Realm Program Management Steward' vs 'HL7 FHIR'
Information | ValueSet.jurisdiction | Removed the item 'urn:iso:std:iso:3166#US'
Error | ValueSet.compose.include[0] | Code 01 removed
Error | ValueSet.compose.include[0] | Code 02 removed
Error | ValueSet.compose.include[0] | Code 03 removed
Error | ValueSet.compose.include[0] | Code 04 removed
Error | ValueSet.compose.include[0] | Code 05 removed
Error | ValueSet.compose.include[0] | Code 06 removed
Error | ValueSet.compose.include[0] | Code 07 removed
Error | ValueSet.compose.include[0] | Code 08 removed
Error | ValueSet.compose.include[0] | Code 09 removed
Error | ValueSet.compose.include[0] | Code 10 removed
Error | ValueSet.compose.include[0] | Code 100 removed
Error | ValueSet.compose.include[0] | Code 101 removed
Error | ValueSet.compose.include[0] | Code 102 removed
Error | ValueSet.compose.include[0] | Code 103 removed
Error | ValueSet.compose.include[0] | Code 104 removed
Error | ValueSet.compose.include[0] | Code 105 removed
Error | ValueSet.compose.include[0] | Code 106 removed
Error | ValueSet.compose.include[0] | Code 107 removed
Error | ValueSet.compose.include[0] | Code 108 removed
Error | ValueSet.compose.include[0] | Code 109 removed
Error | ValueSet.compose.include[0] | Code 11 removed
Error | ValueSet.compose.include[0] | Code 110 removed
Error | ValueSet.compose.include[0] | Code 111 removed
Error | ValueSet.compose.include[0] | Code 112 removed
Error | ValueSet.compose.include[0] | Code 113 removed
Error | ValueSet.compose.include[0] | Code 114 removed
Error | ValueSet.compose.include[0] | Code 115 removed
Error | ValueSet.compose.include[0] | Code 116 removed
Error | ValueSet.compose.include[0] | Code 118 removed
Error | ValueSet.compose.include[0] | Code 119 removed
Error | ValueSet.compose.include[0] | Code 120 removed
Error | ValueSet.compose.include[0] | Code 121 removed
Error | ValueSet.compose.include[0] | Code 122 removed
Error | ValueSet.compose.include[0] | Code 123 removed
Error | ValueSet.compose.include[0] | Code 125 removed
Error | ValueSet.compose.include[0] | Code 126 removed
Error | ValueSet.compose.include[0] | Code 127 removed
Error | ValueSet.compose.include[0] | Code 128 removed
Error | ValueSet.compose.include[0] | Code 129 removed
Error | ValueSet.compose.include[0] | Code 130 removed
Error | ValueSet.compose.include[0] | Code 131 removed
Error | ValueSet.compose.include[0] | Code 132 removed
Error | ValueSet.compose.include[0] | Code 133 removed
Error | ValueSet.compose.include[0] | Code 134 removed
Error | ValueSet.compose.include[0] | Code 135 removed
Error | ValueSet.compose.include[0] | Code 136 removed
Error | ValueSet.compose.include[0] | Code 137 removed
Error | ValueSet.compose.include[0] | Code 138 removed
Error | ValueSet.compose.include[0] | Code 139 removed
Error | ValueSet.compose.include[0] | Code 140 removed
Error | ValueSet.compose.include[0] | Code 141 removed
Error | ValueSet.compose.include[0] | Code 142 removed
Error | ValueSet.compose.include[0] | Code 143 removed
Error | ValueSet.compose.include[0] | Code 144 removed
Error | ValueSet.compose.include[0] | Code 146 removed
Error | ValueSet.compose.include[0] | Code 147 removed
Error | ValueSet.compose.include[0] | Code 148 removed
Error | ValueSet.compose.include[0] | Code 149 removed
Error | ValueSet.compose.include[0] | Code 15 removed
Error | ValueSet.compose.include[0] | Code 150 removed
Error | ValueSet.compose.include[0] | Code 151 removed
Error | ValueSet.compose.include[0] | Code 152 removed
Error | ValueSet.compose.include[0] | Code 153 removed
Error | ValueSet.compose.include[0] | Code 155 removed
Error | ValueSet.compose.include[0] | Code 158 removed
Error | ValueSet.compose.include[0] | Code 16 removed
Error | ValueSet.compose.include[0] | Code 160 removed
Error | ValueSet.compose.include[0] | Code 161 removed
Error | ValueSet.compose.include[0] | Code 162 removed
Error | ValueSet.compose.include[0] | Code 163 removed
Error | ValueSet.compose.include[0] | Code 164 removed
Error | ValueSet.compose.include[0] | Code 165 removed
Error | ValueSet.compose.include[0] | Code 166 removed
Error | ValueSet.compose.include[0] | Code 167 removed
Error | ValueSet.compose.include[0] | Code 168 removed
Error | ValueSet.compose.include[0] | Code 169 removed
Error | ValueSet.compose.include[0] | Code 17 removed
Error | ValueSet.compose.include[0] | Code 170 removed
Error | ValueSet.compose.include[0] | Code 171 removed
Error | ValueSet.compose.include[0] | Code 172 removed
Error | ValueSet.compose.include[0] | Code 173 removed
Error | ValueSet.compose.include[0] | Code 174 removed
Error | ValueSet.compose.include[0] | Code 175 removed
Error | ValueSet.compose.include[0] | Code 176 removed
Error | ValueSet.compose.include[0] | Code 177 removed
Error | ValueSet.compose.include[0] | Code 178 removed
Error | ValueSet.compose.include[0] | Code 179 removed
Error | ValueSet.compose.include[0] | Code 18 removed
Error | ValueSet.compose.include[0] | Code 182 removed
Error | ValueSet.compose.include[0] | Code 183 removed
Error | ValueSet.compose.include[0] | Code 184 removed
Error | ValueSet.compose.include[0] | Code 185 removed
Error | ValueSet.compose.include[0] | Code 186 removed
Error | ValueSet.compose.include[0] | Code 187 removed
Error | ValueSet.compose.include[0] | Code 188 removed
Error | ValueSet.compose.include[0] | Code 189 removed
Error | ValueSet.compose.include[0] | Code 19 removed
Error | ValueSet.compose.include[0] | Code 190 removed
Error | ValueSet.compose.include[0] | Code 191 removed
Error | ValueSet.compose.include[0] | Code 192 removed
Error | ValueSet.compose.include[0] | Code 193 removed
Error | ValueSet.compose.include[0] | Code 194 removed
Error | ValueSet.compose.include[0] | Code 195 removed
Error | ValueSet.compose.include[0] | Code 196 removed
Error | ValueSet.compose.include[0] | Code 197 removed
Error | ValueSet.compose.include[0] | Code 198 removed
Error | ValueSet.compose.include[0] | Code 20 removed
Error | ValueSet.compose.include[0] | Code 200 removed
Error | ValueSet.compose.include[0] | Code 201 removed
Error | ValueSet.compose.include[0] | Code 202 removed
Error | ValueSet.compose.include[0] | Code 203 removed
Error | ValueSet.compose.include[0] | Code 204 removed
Error | ValueSet.compose.include[0] | Code 205 removed
Error | ValueSet.compose.include[0] | Code 206 removed
Error | ValueSet.compose.include[0] | Code 207 removed
Error | ValueSet.compose.include[0] | Code 208 removed
Error | ValueSet.compose.include[0] | Code 21 removed
Error | ValueSet.compose.include[0] | Code 210 removed
Error | ValueSet.compose.include[0] | Code 211 removed
Error | ValueSet.compose.include[0] | Code 212 removed
Error | ValueSet.compose.include[0] | Code 213 removed
Error | ValueSet.compose.include[0] | Code 214 removed
Error | ValueSet.compose.include[0] | Code 215 removed
Error | ValueSet.compose.include[0] | Code 216 removed
Error | ValueSet.compose.include[0] | Code 217 removed
Error | ValueSet.compose.include[0] | Code 218 removed
Error | ValueSet.compose.include[0] | Code 219 removed
Error | ValueSet.compose.include[0] | Code 22 removed
Error | ValueSet.compose.include[0] | Code 220 removed
Error | ValueSet.compose.include[0] | Code 221 removed
Error | ValueSet.compose.include[0] | Code 222 removed
Error | ValueSet.compose.include[0] | Code 223 removed
Error | ValueSet.compose.include[0] | Code 224 removed
Error | ValueSet.compose.include[0] | Code 227 removed
Error | ValueSet.compose.include[0] | Code 228 removed
Error | ValueSet.compose.include[0] | Code 229 removed
Error | ValueSet.compose.include[0] | Code 23 removed
Error | ValueSet.compose.include[0] | Code 230 removed
Error | ValueSet.compose.include[0] | Code 231 removed
Error | ValueSet.compose.include[0] | Code 24 removed
Error | ValueSet.compose.include[0] | Code 25 removed
Error | ValueSet.compose.include[0] | Code 26 removed
Error | ValueSet.compose.include[0] | Code 28 removed
Error | ValueSet.compose.include[0] | Code 300 removed
Error | ValueSet.compose.include[0] | Code 301 removed
Error | ValueSet.compose.include[0] | Code 302 removed
Error | ValueSet.compose.include[0] | Code 303 removed
Error | ValueSet.compose.include[0] | Code 304 removed
Error | ValueSet.compose.include[0] | Code 305 removed
Error | ValueSet.compose.include[0] | Code 306 removed
Error | ValueSet.compose.include[0] | Code 307 removed
Error | ValueSet.compose.include[0] | Code 308 removed
Error | ValueSet.compose.include[0] | Code 309 removed
Error | ValueSet.compose.include[0] | Code 31 removed
Error | ValueSet.compose.include[0] | Code 310 removed
Error | ValueSet.compose.include[0] | Code 311 removed
Error | ValueSet.compose.include[0] | Code 312 removed
Error | ValueSet.compose.include[0] | Code 313 removed
Error | ValueSet.compose.include[0] | Code 314 removed
Error | ValueSet.compose.include[0] | Code 315 removed
Error | ValueSet.compose.include[0] | Code 316 removed
Error | ValueSet.compose.include[0] | Code 317 removed
Error | ValueSet.compose.include[0] | Code 318 removed
Error | ValueSet.compose.include[0] | Code 319 removed
Error | ValueSet.compose.include[0] | Code 32 removed
Error | ValueSet.compose.include[0] | Code 320 removed
Error | ValueSet.compose.include[0] | Code 321 removed
Error | ValueSet.compose.include[0] | Code 322 removed
Error | ValueSet.compose.include[0] | Code 323 removed
Error | ValueSet.compose.include[0] | Code 324 removed
Error | ValueSet.compose.include[0] | Code 326 removed
Error | ValueSet.compose.include[0] | Code 327 removed
Error | ValueSet.compose.include[0] | Code 33 removed
Error | ValueSet.compose.include[0] | Code 35 removed
Error | ValueSet.compose.include[0] | Code 37 removed
Error | ValueSet.compose.include[0] | Code 38 removed
Error | ValueSet.compose.include[0] | Code 39 removed
Error | ValueSet.compose.include[0] | Code 40 removed
Error | ValueSet.compose.include[0] | Code 41 removed
Error | ValueSet.compose.include[0] | Code 42 removed
Error | ValueSet.compose.include[0] | Code 43 removed
Error | ValueSet.compose.include[0] | Code 44 removed
Error | ValueSet.compose.include[0] | Code 45 removed
Error | ValueSet.compose.include[0] | Code 46 removed
Error | ValueSet.compose.include[0] | Code 47 removed
Error | ValueSet.compose.include[0] | Code 48 removed
Error | ValueSet.compose.include[0] | Code 49 removed
Error | ValueSet.compose.include[0] | Code 50 removed
Error | ValueSet.compose.include[0] | Code 500 removed
Error | ValueSet.compose.include[0] | Code 501 removed
Error | ValueSet.compose.include[0] | Code 502 removed
Error | ValueSet.compose.include[0] | Code 503 removed
Error | ValueSet.compose.include[0] | Code 504 removed
Error | ValueSet.compose.include[0] | Code 505 removed
Error | ValueSet.compose.include[0] | Code 506 removed
Error | ValueSet.compose.include[0] | Code 507 removed
Error | ValueSet.compose.include[0] | Code 508 removed
Error | ValueSet.compose.include[0] | Code 509 removed
Error | ValueSet.compose.include[0] | Code 51 removed
Error | ValueSet.compose.include[0] | Code 510 removed
Error | ValueSet.compose.include[0] | Code 511 removed
Error | ValueSet.compose.include[0] | Code 512 removed
Error | ValueSet.compose.include[0] | Code 513 removed
Error | ValueSet.compose.include[0] | Code 514 removed
Error | ValueSet.compose.include[0] | Code 515 removed
Error | ValueSet.compose.include[0] | Code 516 removed
Error | ValueSet.compose.include[0] | Code 517 removed
Error | ValueSet.compose.include[0] | Code 518 removed
Error | ValueSet.compose.include[0] | Code 519 removed
Error | ValueSet.compose.include[0] | Code 52 removed
Error | ValueSet.compose.include[0] | Code 520 removed
Error | ValueSet.compose.include[0] | Code 521 removed
Error | ValueSet.compose.include[0] | Code 53 removed
Error | ValueSet.compose.include[0] | Code 54 removed
Error | ValueSet.compose.include[0] | Code 55 removed
Error | ValueSet.compose.include[0] | Code 56 removed
Error | ValueSet.compose.include[0] | Code 62 removed
Error | ValueSet.compose.include[0] | Code 66 removed
Error | ValueSet.compose.include[0] | Code 69 removed
Error | ValueSet.compose.include[0] | Code 74 removed
Error | ValueSet.compose.include[0] | Code 75 removed
Error | ValueSet.compose.include[0] | Code 77 removed
Error | ValueSet.compose.include[0] | Code 78 removed
Error | ValueSet.compose.include[0] | Code 80 removed
Error | ValueSet.compose.include[0] | Code 81 removed
Error | ValueSet.compose.include[0] | Code 82 removed
Error | ValueSet.compose.include[0] | Code 83 removed
Error | ValueSet.compose.include[0] | Code 84 removed
Error | ValueSet.compose.include[0] | Code 85 removed
Error | ValueSet.compose.include[0] | Code 88 removed
Error | ValueSet.compose.include[0] | Code 89 removed
Error | ValueSet.compose.include[0] | Code 90 removed
Error | ValueSet.compose.include[0] | Code 91 removed
Error | ValueSet.compose.include[0] | Code 92 removed
Error | ValueSet.compose.include[0] | Code 94 removed

### Metadata

Name | Value | Comments
--- | --- | ---
compose.inactive |  |
compose.lockedDate |  |
copyright |  |
date | 2025-04-11T01:08:38-04:00 | 2019-11-01T09:29:23+11:00 | Values Differ
description |  | This identifies the vaccine substance administered - CVX codes. | Added the item 'This identifies the vaccine substance administered - CVX codes.'
experimental |  | false | Added the item 'false'
immutable |  |
jurisdiction |  |
jurisdiction[0] | urn:iso:std:iso:3166#US |  | Removed the item 'urn:iso:std:iso:3166#US'
name | CVXVaccinesAdministeredVaccineSet | VaccineAdministeredValueSet | Values Differ
publisher | HL7 US Realm Program Management Steward | HL7 FHIR | Values Differ
purpose | (Clinical Focus: CVX vaccine concepts that represent actual vaccines types, including those that are historical record of a vaccine administered where the exact formulation is unknown. This does not include the identifiers for CVX codes that are administrative codes or never active codes. Available at http://www2a.cdc.gov/vaccines/iis/iisstandards/vaccines.asp?rpt=cvx),(Data Element Scope: Vaccine representation),(Inclusion Criteria: Any CVX code with "CVX status" (VSAC Property) = Active, Inactive, Non-US except those noted in exclusions),(Exclusion Criteria: CVX codes that have a CVX "status" of either "Pending" or "Never Active" AND CVX codes with CVX "Nonvaccine" property = True.) |  | Removed the item '(Clinical Focus: CVX vaccine concepts that represent actual vaccines types, including those that are historical record of a vaccine administered where the exact formulation is unknown. This does not include the identifiers for CVX codes that are administrative codes or never active codes. Available at http://www2a.cdc.gov/vaccines/iis/iisstandards/vaccines.asp?rpt=cvx),(Data Element Scope: Vaccine representation),(Inclusion Criteria: Any CVX code with "CVX status" (VSAC Property) = Active, Inactive, Non-US except those noted in exclusions),(Exclusion Criteria: CVX codes that have a CVX "status" of either "Pending" or "Never Active" AND CVX codes with CVX "Nonvaccine" property = True.)'
status | active |
title | CVX Vaccines Administered Vaccine Set | Vaccine Administered Value Set | Values Differ
url | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1010.6 | http://hl7.org/fhir/ValueSet/vaccine-code | Values Differ
version | 20250411 | 4.0.1 | Values Differ

### Definition

Item | Property | Value | Comments
--- | --- | --- | ---
include | http://hl7.org/fhir/sid/cvx |  |
Concept | 01 |  | Version: diphtheria, tetanus toxoids and pertussis vaccine |  | Removed this Concept
Concept | 02 |  | Version: trivalent poliovirus vaccine, live, oral |  | Removed this Concept
Concept | 03 |  | Version: measles, mumps and rubella virus vaccine |  | Removed this Concept
Concept | 04 |  | Version: measles and rubella virus vaccine |  | Removed this Concept
Concept | 05 |  | Version: measles virus vaccine |  | Removed this Concept
Concept | 06 |  | Version: rubella virus vaccine |  | Removed this Concept
Concept | 07 |  | Version: mumps virus vaccine |  | Removed this Concept
Concept | 08 |  | Version: hepatitis B vaccine, pediatric or pediatric/adolescent dosage |  | Removed this Concept
Concept | 09 |  | Version: tetanus and diphtheria toxoids, adsorbed, preservative free, for adult use (2 Lf of tetanus toxoid and 2 Lf of diphtheria toxoid) |  | Removed this Concept
Concept | 10 |  | Version: poliovirus vaccine, inactivated |  | Removed this Concept
Concept | 100 |  | Version: pneumococcal conjugate vaccine, 7 valent |  | Removed this Concept
Concept | 101 |  | Version: typhoid Vi capsular polysaccharide vaccine |  | Removed this Concept
Concept | 102 |  | Version: DTP- Haemophilus influenzae type b conjugate and hepatitis b vaccine |  | Removed this Concept
Concept | 103 |  | Version: meningococcal C conjugate vaccine |  | Removed this Concept
Concept | 104 |  | Version: hepatitis A and hepatitis B vaccine |  | Removed this Concept
Concept | 105 |  | Version: vaccinia (smallpox) vaccine, diluted |  | Removed this Concept
Concept | 106 |  | Version: diphtheria, tetanus toxoids and acellular pertussis vaccine, 5 pertussis antigens |  | Removed this Concept
Concept | 107 |  | Version: diphtheria, tetanus toxoids and acellular pertussis vaccine, unspecified formulation |  | Removed this Concept
Concept | 108 |  | Version: meningococcal ACWY vaccine, unspecified formulation |  | Removed this Concept
Concept | 109 |  | Version: pneumococcal vaccine, unspecified formulation |  | Removed this Concept
Concept | 11 |  | Version: pertussis vaccine |  | Removed this Concept
Concept | 110 |  | Version: DTaP-hepatitis B and poliovirus vaccine |  | Removed this Concept
Concept | 111 |  | Version: Influenza, live, trivalent, intranasal |  | Removed this Concept
Concept | 112 |  | Version: tetanus toxoid, unspecified formulation |  | Removed this Concept
Concept | 113 |  | Version: tetanus and diphtheria toxoids, adsorbed, preservative free, for adult use (5 Lf of tetanus toxoid and 2 Lf of diphtheria toxoid) |  | Removed this Concept
Concept | 114 |  | Version: meningococcal polysaccharide (groups A, C, Y and W-135) diphtheria toxoid conjugate vaccine (MCV4P) |  | Removed this Concept
Concept | 115 |  | Version: tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccine, adsorbed |  | Removed this Concept
Concept | 116 |  | Version: rotavirus, live, pentavalent vaccine |  | Removed this Concept
Concept | 118 |  | Version: human papilloma virus vaccine, bivalent |  | Removed this Concept
Concept | 119 |  | Version: rotavirus, live, monovalent vaccine |  | Removed this Concept
Concept | 120 |  | Version: diphtheria, tetanus toxoids and acellular pertussis vaccine, Haemophilus influenzae type b conjugate, and poliovirus vaccine, inactivated (DTaP-Hib-IPV) |  | Removed this Concept
Concept | 121 |  | Version: zoster vaccine, live |  | Removed this Concept
Concept | 122 |  | Version: rotavirus vaccine, unspecified formulation |  | Removed this Concept
Concept | 123 |  | Version: influenza virus vaccine, H5N1, A/Vietnam/1203/2004 (national stockpile) |  | Removed this Concept
Concept | 125 |  | Version: Novel Influenza-H1N1-09, live virus for nasal administration |  | Removed this Concept
Concept | 126 |  | Version: Novel influenza-H1N1-09, preservative-free, injectable |  | Removed this Concept
Concept | 127 |  | Version: Novel influenza-H1N1-09, injectable |  | Removed this Concept
Concept | 128 |  | Version: Novel influenza-H1N1-09, all formulations |  | Removed this Concept
Concept | 129 |  | Version: Japanese Encephalitis vaccine, unspecified formulation |  | Removed this Concept
Concept | 130 |  | Version: Diphtheria, tetanus toxoids and acellular pertussis vaccine, and poliovirus vaccine, inactivated |  | Removed this Concept
Concept | 131 |  | Version: Historical record of a typhus vaccination |  | Removed this Concept
Concept | 132 |  | Version: Historical diphtheria and tetanus toxoids and acellular pertussis, poliovirus, Haemophilus b conjugate and hepatitis B (recombinant) vaccine. |  | Removed this Concept
Concept | 133 |  | Version: pneumococcal conjugate vaccine, 13 valent |  | Removed this Concept
Concept | 134 |  | Version: Japanese Encephalitis vaccine for intramuscular administration |  | Removed this Concept
Concept | 135 |  | Version: Influenza, high-dose, split virus, trivalent, injectable, preservative free |  | Removed this Concept
Concept | 136 |  | Version: meningococcal oligosaccharide (groups A, C, Y and W-135) diphtheria toxoid conjugate vaccine (MCV4O) |  | Removed this Concept
Concept | 137 |  | Version: HPV, unspecified formulation |  | Removed this Concept
Concept | 138 |  | Version: tetanus and diphtheria toxoids, not adsorbed, for adult use |  | Removed this Concept
Concept | 139 |  | Version: Td(adult) unspecified formulation |  | Removed this Concept
Concept | 140 |  | Version: Influenza, split virus, trivalent, injectable, preservative free |  | Removed this Concept
Concept | 141 |  | Version: Influenza, split virus, trivalent, injectable, contains preservative |  | Removed this Concept
Concept | 142 |  | Version: tetanus toxoid, not adsorbed |  | Removed this Concept
Concept | 143 |  | Version: Adenovirus, type 4 and type 7, live, oral |  | Removed this Concept
Concept | 144 |  | Version: seasonal influenza, intradermal, preservative free |  | Removed this Concept
Concept | 146 |  | Version: Diphtheria and Tetanus Toxoids and Acellular Pertussis Adsorbed, Inactivated Poliovirus, Haemophilus b Conjugate (Meningococcal Protein Conjugate), and Hepatitis B (Recombinant) Vaccine. |  | Removed this Concept
Concept | 147 |  | Version: Meningococcal, MCV4, unspecified conjugate formulation(groups A, C, Y and W-135) |  | Removed this Concept
Concept | 148 |  | Version: Meningococcal Groups C and Y and Haemophilus b Tetanus Toxoid Conjugate Vaccine |  | Removed this Concept
Concept | 149 |  | Version: Influenza, live, quadrivalent, intranasal |  | Removed this Concept
Concept | 15 |  | Version: influenza virus vaccine, split virus (incl. purified surface antigen)-retired CODE |  | Removed this Concept
Concept | 150 |  | Version: Influenza, split virus, quadrivalent, injectable, preservative free |  | Removed this Concept
Concept | 151 |  | Version: influenza nasal, unspecified formulation |  | Removed this Concept
Concept | 152 |  | Version: Pneumococcal Conjugate, unspecified formulation |  | Removed this Concept
Concept | 153 |  | Version: Influenza, Madin Darby Canine Kidney, subunit, trivalent, injectable, preservative free |  | Removed this Concept
Concept | 155 |  | Version: Influenza, recombinant, trivalent, injectable, preservative free |  | Removed this Concept
Concept | 158 |  | Version: Influenza, split virus, quadrivalent, injectable, contains preservative |  | Removed this Concept
Concept | 16 |  | Version: influenza virus vaccine, whole virus |  | Removed this Concept
Concept | 160 |  | Version: Influenza A monovalent (H5N1), adjuvanted, National stockpile 2013 |  | Removed this Concept
Concept | 161 |  | Version: Influenza, injectable,quadrivalent, preservative free, pediatric |  | Removed this Concept
Concept | 162 |  | Version: meningococcal B vaccine, fully recombinant |  | Removed this Concept
Concept | 163 |  | Version: meningococcal B vaccine, recombinant, OMV, adjuvanted |  | Removed this Concept
Concept | 164 |  | Version: meningococcal B, unspecified formulation |  | Removed this Concept
Concept | 165 |  | Version: Human Papillomavirus 9-valent vaccine |  | Removed this Concept
Concept | 166 |  | Version: influenza, intradermal, quadrivalent, preservative free, injectable |  | Removed this Concept
Concept | 167 |  | Version: meningococcal vaccine of unknown formulation and unknown serogroups |  | Removed this Concept
Concept | 168 |  | Version: Influenza, adjuvanted, inactivated, trivalent, injectable, preservative free |  | Removed this Concept
Concept | 169 |  | Version: Hep A, live attenuated-IM |  | Removed this Concept
Concept | 17 |  | Version: Haemophilus influenzae type b vaccine, conjugate unspecified formulation |  | Removed this Concept
Concept | 170 |  | Version: non-US diphtheria, tetanus toxoids and acellular pertussis vaccine, Haemophilus influenzae type b conjugate, and poliovirus vaccine, inactivated (DTaP-Hib-IPV) |  | Removed this Concept
Concept | 171 |  | Version: Influenza, Madin Darby Canine Kidney, subunit, quadrivalent, injectable, preservative free |  | Removed this Concept
Concept | 172 |  | Version: cholera, WC-rBS |  | Removed this Concept
Concept | 173 |  | Version: cholera, BivWC |  | Removed this Concept
Concept | 174 |  | Version: cholera, live attenuated |  | Removed this Concept
Concept | 175 |  | Version: Human Rabies vaccine from human diploid cell culture |  | Removed this Concept
Concept | 176 |  | Version: Human rabies vaccine from Chicken fibroblast culture |  | Removed this Concept
Concept | 177 |  | Version: pneumococcal conjugate vaccine, 10 valent |  | Removed this Concept
Concept | 178 |  | Version: Non-US bivalent oral polio vaccine (types 1 and 3) |  | Removed this Concept
Concept | 179 |  | Version: Non-US monovalent oral polio vaccine, unspecified formulation |  | Removed this Concept
Concept | 18 |  | Version: rabies vaccine, for intramuscular injection RETIRED CODE |  | Removed this Concept
Concept | 182 |  | Version: Oral Polio Vaccine, Unspecified formulation |  | Removed this Concept
Concept | 183 |  | Version: Yellow fever vaccine live - alternative formulation for vaccine shortage |  | Removed this Concept
Concept | 184 |  | Version: Yellow fever vaccine, unspecified formulation |  | Removed this Concept
Concept | 185 |  | Version: Influenza, recombinant, quadrivalent, injectable, preservative free |  | Removed this Concept
Concept | 186 |  | Version: Influenza, Madin Darby Canine Kidney, subunit, quadrivalent, injectable, contains preservative |  | Removed this Concept
Concept | 187 |  | Version: zoster vaccine recombinant |  | Removed this Concept
Concept | 188 |  | Version: zoster vaccine, unspecified formulation |  | Removed this Concept
Concept | 189 |  | Version: Hepatitis B vaccine (recombinant), CpG adjuvanted |  | Removed this Concept
Concept | 19 |  | Version: Bacillus Calmette-Guerin vaccine |  | Removed this Concept
Concept | 190 |  | Version: Typhoid conjugate vaccine (non-US) |  | Removed this Concept
Concept | 191 |  | Version: meningococcal A polysaccharide vaccine (non-US) |  | Removed this Concept
Concept | 192 |  | Version: meningococcal AC polysaccharide vaccine (non-US) |  | Removed this Concept
Concept | 193 |  | Version: hepatitis A and hepatitis B vaccine, pediatric/adolescent (non-US) |  | Removed this Concept
Concept | 194 |  | Version: influenza, Southern Hemisphere, unspecified formulation |  | Removed this Concept
Concept | 195 |  | Version: Diphtheria, Tetanus, Poliomyelitis adsorbed |  | Removed this Concept
Concept | 196 |  | Version: tetanus and diphtheria toxoids, adsorbed, preservative free, for adult use, Lf unspecified |  | Removed this Concept
Concept | 197 |  | Version: Influenza, high-dose, split virus, quadrivalent, injectable, preservative free |  | Removed this Concept
Concept | 198 |  | Version: Diphtheria, pertussis, tetanus, hepatitis B, Haemophilus Influenza Type b, (Pentavalent) |  | Removed this Concept
Concept | 20 |  | Version: diphtheria, tetanus toxoids and acellular pertussis vaccine |  | Removed this Concept
Concept | 200 |  | Version: influenza, seasonal, Southern Hemisphere, quadrivalent, pediatric 0.25mL dose, preservative free |  | Removed this Concept
Concept | 201 |  | Version: influenza, seasonal, Southern Hemisphere, quadrivalent, 0.5mL dose, no preservative |  | Removed this Concept
Concept | 202 |  | Version: influenza, seasonal, Southern Hemisphere, quadrivalent, 0.5mL dose, with preservative |  | Removed this Concept
Concept | 203 |  | Version: meningococcal polysaccharide (groups A, C, Y, W-135) tetanus toxoid conjugate vaccine 0.5mL dose, preservative free |  | Removed this Concept
Concept | 204 |  | Version: Ebola Zaire vaccine, live, recombinant, 1mL dose |  | Removed this Concept
Concept | 205 |  | Version: Influenza, adjuvanted, inactivated, quadrivalent, injectable, preservative free |  | Removed this Concept
Concept | 206 |  | Version: Vaccinia, smallpox monkeypox vaccine, live attenuated, preservative free, subcutaneous or intradermal injection |  | Removed this Concept
Concept | 207 |  | Version: SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, preservative free, 100 mcg/0.5mL dose or 50 mcg/0.25mL dose |  | Removed this Concept
Concept | 208 |  | Version: SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, preservative free, 30 mcg/0.3mL dose |  | Removed this Concept
Concept | 21 |  | Version: varicella virus vaccine |  | Removed this Concept
Concept | 210 |  | Version: SARS-COV-2 (COVID-19) vaccine, vector non-replicating, recombinant spike protein-ChAdOx1, preservative free, 0.5 mL |  | Removed this Concept
Concept | 211 |  | Version: SARS-COV-2 (COVID-19) vaccine, subunit, recombinant spike protein-nanoparticle+Matrix-M1 Adjuvant, preservative free, 0.5mL dose |  | Removed this Concept
Concept | 212 |  | Version: SARS-COV-2 (COVID-19) vaccine, vector non-replicating, recombinant spike protein-Ad26, preservative free, 0.5 mL |  | Removed this Concept
Concept | 213 |  | Version: SARS-COV-2 (COVID-19) vaccine, UNSPECIFIED |  | Removed this Concept
Concept | 214 |  | Version: Ebola, unspecified |  | Removed this Concept
Concept | 215 |  | Version: Pneumococcal conjugate vaccine 15-valent (PCV15), polysaccharide CRM197 conjugate, adjuvant, preservative free |  | Removed this Concept
Concept | 216 |  | Version: Pneumococcal conjugate vaccine 20-valent (PCV20), polysaccharide CRM197 conjugate, adjuvant, preservative free |  | Removed this Concept
Concept | 217 |  | Version: SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, preservative free, 30 mcg/0.3mL dose, tris-sucrose formulation |  | Removed this Concept
Concept | 218 |  | Version: SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, preservative free, 10 mcg/0.2mL dose, tris-sucrose formulation |  | Removed this Concept
Concept | 219 |  | Version: SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, preservative free, 3 mcg/0.2mL dose, tris-sucrose formulation |  | Removed this Concept
Concept | 22 |  | Version: DTP-Haemophilus influenzae type b conjugate vaccine |  | Removed this Concept
Concept | 220 |  | Version: Hepatitis B vaccine (recombinant), 3-antigen, Al(OH)3 adjuvanted |  | Removed this Concept
Concept | 221 |  | Version: SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, preservative free, 50 mcg/0.5 mL dose |  | Removed this Concept
Concept | 222 |  | Version: Tick-borne encephalitis vaccine, unspecified |  | Removed this Concept
Concept | 223 |  | Version: Tick-borne encephalitis vaccine, inactivated, preservative free, 0.25mL dose |  | Removed this Concept
Concept | 224 |  | Version: Tick-borne encephalitis vaccine, inactivated, preservative free, 0.5mL dose |  | Removed this Concept
Concept | 227 |  | Version: SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, preservative free, pediatric 50 mcg/0.5 mL dose |  | Removed this Concept
Concept | 228 |  | Version: SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, preservative free, pediatric 25 mcg/0.25 mL dose |  | Removed this Concept
Concept | 229 |  | Version: SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, bivalent, preservative free, 50 mcg/0.5 mL or 25 mcg/0.25 mL dose |  | Removed this Concept
Concept | 23 |  | Version: plague vaccine |  | Removed this Concept
Concept | 230 |  | Version: SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, bivalent, preservative free, 10 mcg/0.2 mL dose |  | Removed this Concept
Concept | 231 |  | Version: influenza, seasonal, Southern Hemisphere, high-dose, quadrivalent, 0.7mL dose, preservative free |  | Removed this Concept
Concept | 24 |  | Version: Anthrax vaccine, adsorbed, pre-exposure and post-exposure prophylaxis |  | Removed this Concept
Concept | 25 |  | Version: typhoid vaccine, live, oral |  | Removed this Concept
Concept | 26 |  | Version: cholera vaccine, unspecified formulation |  | Removed this Concept
Concept | 28 |  | Version: diphtheria and tetanus toxoids, adsorbed for pediatric use |  | Removed this Concept
Concept | 300 |  | Version: SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, bivalent, preservative free, 30 mcg/0.3 mL dose, tris-sucrose formulation |  | Removed this Concept
Concept | 301 |  | Version: SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, bivalent, preservative free, 10 mcg/0.2 mL dose, tris-sucrose formulation |  | Removed this Concept
Concept | 302 |  | Version: SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, bivalent, preservative free, 3 mcg/0.2 mL dose, tris-sucrose formulation |  | Removed this Concept
Concept | 303 |  | Version: Respiratory syncytial virus (RSV), vaccine, recombinant, protein subunit RSV prefusion F, adjuvant reconstituted, 0.5 mL, preservative free |  | Removed this Concept
Concept | 304 |  | Version: Respiratory syncytial virus (RSV), unspecified |  | Removed this Concept
Concept | 305 |  | Version: Respiratory syncytial virus (RSV), vaccine, bivalent, protein subunit RSV prefusion F, diluent reconstituted, 0.5 mL, preservative free |  | Removed this Concept
Concept | 306 |  | Version: Respiratory syncytial virus (RSV) monoclonal antibody, IgG1κ, (nirsevimab-alip), 0.5 mL, neonates and children to 24 months |  | Removed this Concept
Concept | 307 |  | Version: Respiratory syncytial virus (RSV) monoclonal antibody, IgG1κ, (nirsevimab-alip), 1 mL, neonates and children to 24 months |  | Removed this Concept
Concept | 308 |  | Version: SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, preservative free, tris-sucrose, 3 mcg/0.3 mL dose |  | Removed this Concept
Concept | 309 |  | Version: SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, preservative free, tris-sucrose, 30 mcg/0.3 mL dose |  | Removed this Concept
Concept | 31 |  | Version: hepatitis A vaccine, pediatric dosage, unspecified formulation |  | Removed this Concept
Concept | 310 |  | Version: SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, preservative free, tris-sucrose, 10 mcg/0.3 mL dose |  | Removed this Concept
Concept | 311 |  | Version: SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, preservative free, 25 mcg/0.25 mL dose |  | Removed this Concept
Concept | 312 |  | Version: SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, preservative free, 50 mcg/0.5 mL dose |  | Removed this Concept
Concept | 313 |  | Version: SARS-COV-2 (COVID-19) vaccine, subunit, recombinant spike protein-nanoparticle+Matrix-M1 Adjuvant, preservative free, 5 mcg/0.5 mL dose |  | Removed this Concept
Concept | 314 |  | Version: Respiratory syncytial virus (RSV) vaccine, unspecified |  | Removed this Concept
Concept | 315 |  | Version: Respiratory syncytial virus (RSV) monoclonal antibody (MAB), unspecified |  | Removed this Concept
Concept | 316 |  | Version: Meningococcal polysaccharide (groups A, C, Y, W) tetanus toxoid conjugate, meningococcal B recombinant vaccine, 0.5mL, preservative free |  | Removed this Concept
Concept | 317 |  | Version: Chikungunya, live attenuated vaccine, 0.5 mL, preservative free |  | Removed this Concept
Concept | 318 |  | Version: Anthrax vaccine, adsorbed, adjuvanted, post-exposure prophylaxis |  | Removed this Concept
Concept | 319 |  | Version: Anthrax vaccine, unspecified |  | Removed this Concept
Concept | 32 |  | Version: meningococcal polysaccharide vaccine (MPSV4) |  | Removed this Concept
Concept | 320 |  | Version: Influenza, Madin Darby Canine Kidney, subunit, trivalent, injectable, contains preservative |  | Removed this Concept
Concept | 321 |  | Version: Influenza-avian, H5N8, viral-vector, monovalent, injectable, preservative free |  | Removed this Concept
Concept | 322 |  | Version: Influenza-avian, H5N8, viral-vector, monovalent, injectable, contains preservative |  | Removed this Concept
Concept | 323 |  | Version: Influenza-avian, H5, unspecified formulation |  | Removed this Concept
Concept | 324 |  | Version: Poliovirus, inactivated, fractional-dose (fIPV) |  | Removed this Concept
Concept | 326 |  | Version: Respiratory syncytial virus (RSV), mRNA, injectable, preservative free |  | Removed this Concept
Concept | 327 |  | Version: Pneumococcal conjugate vaccine, 21 valent (PCV21), polysaccharide CRM197 conjugate, preservative free |  | Removed this Concept
Concept | 33 |  | Version: pneumococcal polysaccharide vaccine, 23 valent |  | Removed this Concept
Concept | 35 |  | Version: tetanus toxoid, adsorbed |  | Removed this Concept
Concept | 37 |  | Version: yellow fever vaccine live |  | Removed this Concept
Concept | 38 |  | Version: rubella and mumps virus vaccine |  | Removed this Concept
Concept | 39 |  | Version: Japanese Encephalitis Vaccine SC |  | Removed this Concept
Concept | 40 |  | Version: rabies vaccine, for intradermal injection |  | Removed this Concept
Concept | 41 |  | Version: typhoid vaccine, parenteral, other than acetone-killed, dried |  | Removed this Concept
Concept | 42 |  | Version: hepatitis B vaccine, adolescent/high risk infant dosage |  | Removed this Concept
Concept | 43 |  | Version: hepatitis B vaccine, adult dosage |  | Removed this Concept
Concept | 44 |  | Version: Hepatitis B vaccine (Hep B), high-dosage, dialysis or immunocompromised patient |  | Removed this Concept
Concept | 45 |  | Version: hepatitis B vaccine, unspecified formulation |  | Removed this Concept
Concept | 46 |  | Version: Haemophilus influenzae type b vaccine, PRP-D conjugate |  | Removed this Concept
Concept | 47 |  | Version: Haemophilus influenzae type b vaccine, HbOC conjugate |  | Removed this Concept
Concept | 48 |  | Version: Haemophilus influenzae type b vaccine, PRP-T conjugate |  | Removed this Concept
Concept | 49 |  | Version: Haemophilus influenzae type b vaccine, PRP-OMP conjugate |  | Removed this Concept
Concept | 50 |  | Version: DTaP-Haemophilus influenzae type b conjugate vaccine |  | Removed this Concept
Concept | 500 |  | Version: SARS-COV-2 COVID-19 Non-US Vaccine, Specific Product Unknown |  | Removed this Concept
Concept | 501 |  | Version: SARS-COV-2 COVID-19 Inactivated Virus Non-US Vaccine Product (QAZCOVID-IN) |  | Removed this Concept
Concept | 502 |  | Version: SARS-COV-2 COVID-19 Inactivated Virus Non-US Vaccine Product (COVAXIN) |  | Removed this Concept
Concept | 503 |  | Version: SARS-COV-2 COVID-19 Live Attenuated Virus Non-US Vaccine Product (COVIVAC) |  | Removed this Concept
Concept | 504 |  | Version: SARS-COV-2 COVID-19 Viral Vector Non-replicating Non-US Vaccine Product (Sputnik Light) |  | Removed this Concept
Concept | 505 |  | Version: SARS-COV-2 COVID-19 Viral Vector Non-replicating Non-US Vaccine Product (Sputnik V) |  | Removed this Concept
Concept | 506 |  | Version: SARS-COV-2 COVID-19 Viral Vector Non-replicating Non-US Vaccine Product (CONVIDECIA), CanSino Biological Inc./Beijing Institute of Biotechnology |  | Removed this Concept
Concept | 507 |  | Version: SARS-COV-2 COVID-19 Protein Subunit Non-US Vaccine Product (Anhui Zhifei Longcom Biopharmaceutical + Institute of Microbiology, Chinese Academy of Sciences) |  | Removed this Concept
Concept | 508 |  | Version: SARS-COV-2 COVID-19 Protein Subunit Non-US Vaccine Product (Jiangsu Province Centers for Disease Control and Prevention) |  | Removed this Concept
Concept | 509 |  | Version: SARS-COV-2 COVID-19 Protein Subunit Non-US Vaccine Product (EpiVacCorona) |  | Removed this Concept
Concept | 51 |  | Version: Haemophilus influenzae type b conjugate and Hepatitis B vaccine |  | Removed this Concept
Concept | 510 |  | Version: SARS-COV-2 COVID-19 Inactivated Virus Non-US Vaccine Product (BIBP, Sinopharm) |  | Removed this Concept
Concept | 511 |  | Version: SARS-COV-2 COVID-19 Inactivated Virus Non-US Vaccine Product (CoronaVac, Sinovac) |  | Removed this Concept
Concept | 512 |  | Version: SARS-COV-2 COVID-19 Virus Like Particle (VLP) Non-US Vaccine Product (Medicago, Covifenz) |  | Removed this Concept
Concept | 513 |  | Version: SARS-COV-2 COVID-19 Protein Subunit Non-US Vaccine Product (Anhui Zhifei Longcom, Zifivax) |  | Removed this Concept
Concept | 514 |  | Version: SARS-COV-2 COVID-19 DNA Non-US Vaccine Product (Zydus Cadila, ZyCoV-D) |  | Removed this Concept
Concept | 515 |  | Version: SARS-COV-2 COVID-19 Protein Subunit Non-US Vaccine Product (Medigen, MVC-COV1901) |  | Removed this Concept
Concept | 516 |  | Version: SARS-COV-2 COVID-19 Inactivated Non-US Vaccine Product (Minhai Biotechnology Co, KCONVAC) |  | Removed this Concept
Concept | 517 |  | Version: SARS-COV-2 COVID-19 Protein Subunit Non-US Vaccine Product (Biological E Limited, Corbevax) |  | Removed this Concept
Concept | 518 |  | Version: SARS-COV-2 COVID-19 Inactivated, Non-US Vaccine (VLA2001, Valneva) |  | Removed this Concept
Concept | 519 |  | Version: SARS-COV-2 COVID-19 mRNA, bivalent, original/Omicron BA.1, Non-US Vaccine (Spikevax Bivalent), Moderna |  | Removed this Concept
Concept | 52 |  | Version: hepatitis A vaccine, adult dosage |  | Removed this Concept
Concept | 520 |  | Version: SARS-COV-2 COVID-19 mRNA, bivalent, original/Omicron BA.1, Non-US Vaccine Product (Comirnaty Bivalent), Pfizer-BioNTech |  | Removed this Concept
Concept | 521 |  | Version: SARS-COV-2 (COVID-19) vaccine SP, protein-based, adjuvanted, B.1.351 strain (VidPrevtyn Beta), Sanofi-GSK |  | Removed this Concept
Concept | 53 |  | Version: typhoid vaccine, parenteral, acetone-killed, dried (U.S. military) |  | Removed this Concept
Concept | 54 |  | Version: adenovirus vaccine, type 4, live, oral |  | Removed this Concept
Concept | 55 |  | Version: adenovirus vaccine, type 7, live, oral |  | Removed this Concept
Concept | 56 |  | Version: dengue fever vaccine, tetravalent |  | Removed this Concept
Concept | 62 |  | Version: human papilloma virus vaccine, quadrivalent |  | Removed this Concept
Concept | 66 |  | Version: Lyme disease vaccine |  | Removed this Concept
Concept | 69 |  | Version: parainfluenza-3 virus vaccine |  | Removed this Concept
Concept | 74 |  | Version: rotavirus, live, tetravalent vaccine |  | Removed this Concept
Concept | 75 |  | Version: vaccinia (smallpox) vaccine |  | Removed this Concept
Concept | 77 |  | Version: Tick-borne encephalitis vaccine (non-US) |  | Removed this Concept
Concept | 78 |  | Version: tularemia vaccine |  | Removed this Concept
Concept | 80 |  | Version: Venezuelan equine encephalitis, live, attenuated |  | Removed this Concept
Concept | 81 |  | Version: Venezuelan equine encephalitis, inactivated |  | Removed this Concept
Concept | 82 |  | Version: adenovirus vaccine, unspecified formulation |  | Removed this Concept
Concept | 83 |  | Version: hepatitis A vaccine, pediatric/adolescent dosage, 2 dose schedule |  | Removed this Concept
Concept | 84 |  | Version: hepatitis A vaccine, pediatric/adolescent dosage, 3 dose schedule |  | Removed this Concept
Concept | 85 |  | Version: hepatitis A vaccine, unspecified formulation |  | Removed this Concept
Concept | 88 |  | Version: influenza virus vaccine, unspecified formulation |  | Removed this Concept
Concept | 89 |  | Version: poliovirus vaccine, unspecified formulation |  | Removed this Concept
Concept | 90 |  | Version: rabies vaccine, unspecified formulation |  | Removed this Concept
Concept | 91 |  | Version: typhoid vaccine, unspecified formulation |  | Removed this Concept
Concept | 92 |  | Version: Venezuelan equine encephalitis vaccine, unspecified formulation |  | Removed this Concept
Concept | 94 |  | Version: measles, mumps, rubella, and varicella virus vaccine |  | Removed this Concept
include |  | urn:oid:1.2.36.1.2001.1005.17 |  |  | Added Include

### Expansion

Unable to generate expansion - see errors